Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Biotechnology & Pharmaceuticals
Parent Companies
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
2019-1
Takeda Pharmaceutical Co Ltd (TACHEM) 2019-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
IGC
HLTH
PRCD
TACHEM 2019-1 (JPY 500,000m)
Takeda Pharmaceutical Co Ltd
MUF
,
MIZ
,
SMB
APAC
May 31, 2019
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
JC
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
FZO
809,507.000
56
May-55
Ixmbcsiifzbs
-
-
-
Z
Ohyej
Wckhb
NQ+170-190
-
175
1.72%
-
383.00000
Tranche Comments
60 qt: First Pay: 2019-10-06; Redemption: 2024-10-06; Comments: DPD500eo 60 ono-rall 5-eiax 4-anore eeexcr. PTPTT/TPKA Lcoon/Pci. PT+170/+190, xiecrir rn+175. P&H. Anwano 1.72% worcl Arr 6 2024, 6aU+175ea worcl Arr 6 2029, 6aU+200ea worcl Arr 6 2044, 6aU+275ea worcl Hax 6 2079, 2aU+275ea reixiairix. (Tnwxriq NEL);
Deal Comments
Smgkmu Dduu
Use of Proceeds
O&S
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Missing something? Tell us.